Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
about
Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner.HUS and atypical HUS.Eculizumab in secondary atypical haemolytic uraemic syndrome.Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathyCharacterization of C3 in C3 glomerulopathy.Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage.Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery.Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis.Circulating complement levels and C3 glomerulopathy.A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.Treating C3 glomerulopathy with eculizumab.COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series).C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction.
P2860
Q33428410-ECE9EA94-D37F-409D-BF4D-3B7CFBB7FE1AQ33441069-1FC39706-D5E0-4560-8FF4-00E2EEEAF12AQ33620588-30C61246-613B-40A1-B930-B56D36A73E1BQ35877192-CBACB94F-55F9-427C-B050-B3C958D2793BQ36099921-1D37DEB2-D3C7-4E11-8B70-18F1851A69B5Q38549182-F5E9097F-E333-4F98-9241-AD1E1A933D6AQ38879877-DF324450-2AD8-4D7A-AD84-39DA9EF0EF18Q39246952-BF663613-7CAC-4505-81DD-7BB16FBB2AF6Q42392710-521FE7DB-7F45-4B0D-8EB1-0CB5DED7A3AAQ42975970-B9B29981-5561-4526-B908-D70ED0E17E87Q47998588-758C063E-1129-4D96-9D3D-64261AE5626DQ48225126-ADA043E1-1F5A-4286-8A80-B0DCD0320EE6Q48252388-2D911AED-6545-431D-A4FF-FF13D150DF47Q52731057-C307F2E1-D184-4CD2-9253-C6B31F405F49Q55287167-518E26D6-69ED-4F37-8963-225BD2713232
P2860
Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pathology of renal diseases as ...... olytic uremic syndrome (aHUS).
@ast
Pathology of renal diseases as ...... olytic uremic syndrome (aHUS).
@en
type
label
Pathology of renal diseases as ...... olytic uremic syndrome (aHUS).
@ast
Pathology of renal diseases as ...... olytic uremic syndrome (aHUS).
@en
prefLabel
Pathology of renal diseases as ...... olytic uremic syndrome (aHUS).
@ast
Pathology of renal diseases as ...... olytic uremic syndrome (aHUS).
@en
P356
P1476
Pathology of renal diseases as ...... olytic uremic syndrome (aHUS).
@en
P2093
Fernando C Fervenza
Sanjeev Sethi
P304
P356
10.1055/S-0034-1375701
P577
2014-05-05T00:00:00Z